Malaysia Unveils AI-Powered Heart2Miss Breakthroughs At ESC-Heart Failure Congress
Supported by AstraZeneca Malaysia, the initiative uses Us2.AI's state-of-the-art cardiac ultrasound analysis and was launched in June 2024 with backing from Sarawak's Minister of Public Health, Housing and Local Government, Datuk Dr Sim Kui Hian.
In a statement, AstraZeneca said the programme's effectiveness was demonstrated through the screening of 1,000 high-risk patients within a year, identifying 120 positive cases, by using a decentralised, community-based rapid cardiac ultrasound triage model.
'This approach leveraged the expertise of underemployed bioscience graduates as mobile community sonographers, reducing the burden on tertiary centres while enhancing patient referrals and outpatient management.
'Additionally, it facilitated earlier interventions and provided new career opportunities in health diagnostics,' the statement read.
According to the statement, the programme's implementation at Sarawak General Hospital (SGH) has significantly streamlined referrals and outpatient care, cutting patient wait times for appointments from nine months to just a few days at nearby health clinics.
Heart2Miss Principal Investigator Dr Diana Hui-Ping Foo highlighted that the initiative demonstrates the power of combining innovation with equity, leveraging AI-echo (Us2.AI), telehealth and task-shifting to enable early heart failure detection at the community level.
'By training underutilised bioscience graduates as mobile echo screeners and introducing an intermediary care tier, we enhance primary care support and reduce burden on tertiary cardiac services,' said Foo, who is also the SGH Clinician-Researcher and Head of Human Physiology Lab.
Dr Diana Foo spearheaded the study alongside Dr Alan Fong, SGH's Head of Clinical Research Centre. Their collaboration with AstraZeneca Malaysia has been recognised as a model public-private partnership in advancing health outcomes.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Barnama
2 hours ago
- Barnama
Life Moves Festival 2025 By Sunway Medical Centre Aims To Raise Awareness On NCDs
Thousands are expected to turn up for Life Moves Festival 2025 by Sunway Medical Centre (SMC). Credit: Sunway Medical Centre, Sunway City KUALA LUMPUR, July 28 (Bernama) -- Sunway Medical Centre, Sunway City (SMC), Selangor will hold its annual health and wellness event - Life Moves Festival 2025 - at the hospital's Tower D Lobby on Aug 3. SMC said the one-day festival is open to the public from 10 am to 4 pm and aims to raise awareness on non-communicable diseases (NCDs) such as diabetes, cancer and heart disease, while encouraging early detection and healthier lifestyle choices. With the theme 'Every Move Matters, Every Step Counts Against NCDs', the festival will feature preventive healthcare through a dynamic blend of interactive exhibits, complimentary screenings and engaging family-friendly activities. "Festivalgoers can benefit from a range of free basic health checks, including blood glucose tests, body composition analysis and urine tests. "These screenings aim to help attendees gain greater awareness of their current health status and encourage follow-up consultations, where necessary," it said in a statement. It added that one of the festival's standout attractions is the 'Jantungku' Walkthrough Heart Exhibit, offering a close-up view at the human heart to help visitors understand how cardiovascular health is affected by everyday lifestyle choices. "Beyond the screenings and exhibits, the festival also promises a day of light-hearted fun and discovery. Game stations and flash quiz challenges will offer opportunities for all ages to learn about healthy living. "Visitors can also browse the Health Marketplace, showcasing wellness brands, health-centric products and nourishing food options," it said. SMC said the Life Moves Festival is part of its continuous commitment to supporting national public health goals, promoting informed health decisions and encouraging sustainable behavioural change through education and community engagement.
Malay Mail
8 hours ago
- Malay Mail
HKSTP Takes Nine Game-Changing AI Tech Ventures to WAIC 2025 to Advance China's AI Plus Vision in Transforming Business and Industry
HKSTP is embarking on a mission to advance China's AI Plus vision with nine Hong Kong AI park companies at the WAIC 2025. Hong Kong Space Robotics and Energy Centre Limited (HKSRE ) is an InnoHK R&D centre focuses on aerospace technology R&D to foster international collaboration for the Chang'e-8 mission. It brings together institutions from local and overseas to jointly develop the mission's Hong Kong-operated robot—a multifunctional lunar surface operations and mobile charging system. ) is an InnoHK R&D centre focuses on aerospace technology R&D to foster international collaboration for the Chang'e-8 mission. It brings together institutions from local and overseas to jointly develop the mission's Hong Kong-operated robot—a multifunctional lunar surface operations and mobile charging system. Centre for Artificial Intelligence and Robotics ( CAIR ) Hong Kong Institute of Science & Innovation Chinese Academy of Sciences is another InnoHK R&D centre, showcases MicroNeuro, the world's first flexible robotic system for minimally invasive neurosurgery to address challenges of fragile brain tissue and confined spaces, surpassing human surgical limits. ( ) is another InnoHK R&D centre, showcases MicroNeuro, the world's first flexible robotic system for minimally invasive neurosurgery to address challenges of fragile brain tissue and confined spaces, surpassing human surgical limits. Digital Domain, a global leader in Hollywood visual effects and AI virtual human technologies, showcases the AI-powered video creation solution "HANBAO" and "AI DOMAIN", an all-in-one content creation platform, empowering creators to tailor high-quality short videos for online platforms. Digital Domain has set up its state-of-the-art R&D centre in Hong Kong, driving the innovative development among entertainment and cross-industry. Centre for Artificial Intelligence and Robotics, Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences (CAIR) ClusterTech Limited Digital Domain Hong Kong Centre for Cerebro-cardiovascular Health Engineering (COCHE) HK INBOT TECHNOLOGY LIMITED Hong Kong Space Robotics and Energy Centre Limited MattVerse Limited Metapool Technology Limited Ultipa Hong Kong Limited HONG KONG SAR / SHANGHAI, CHINA - Media OutReach Newswire - 27 July 2025 - Hong Kong Science and Technology Parks Corporation (HKSTP) is embarking on a mission to advance China's AI Plus vision with nine Hong Kong AI park companies at the World AI Conference & High-Level Meeting on Global AI Governance (WAIC) 2025, taking place from July 26-29 in Shanghai, China. In collaboration with the Hong Kong Trade Development Council and Cyberport, HKSTP is leveraging Hong Kong's growing global AI innovation hub status to advance the China's strategic AI initiative and applying AI and big data to transform old and new industry sectors to boost a new era of growth."Hong Kong is a crucible for world-class AI innovation and our unique HKSTP ecosystem provides an ideal platform to empower AI tech firms with global fluency and pave the way for global expansion. By taking local tech companies on a global growth journey and attracting more international startups to land Hong Kong and integrating into the Mainland China or even the Asia markets means a growing critical mass of world-class AI innovators is created. This influx of global talent and technology will accelerate the country's high-tech industry and economic development, further fueling the national drive for new quality productive forces."The nine park enterprises participating in the Hong Kong Pavilion cover technologies in life and health tech, fintech, entertainment, aerospace tech, digital education and more, highlights included:In addition to the showcase of tech firms, HKSTP also hosted a provoking panel discussion at WAIC 2025, exploring the theme of: "From Hong Kong to global impact: Shaping the future with AI and New Quality Productive Forces for Cross-industry Growth", moderated by Ms Pheona Kan, Director of Business Development at HKSTP with the fellow scientists and experts from the discussion highlighted how Hong Kong has a unique role in global AI development by uniting international talent and technology behind the city's AI vision which also aligns with China's vision to transform industry through quality productive the largest I&T ecosystem in Hong Kong, HKSTP is home to over 500 AI startups, including home-grown unicorns that are shaping the future of artificial intelligence. In alignment with Hong Kong's bold vision for technological leadership, the HKSTP San Tin Technopole Campus—a 20-hectare site within the soon-to-be-built San Tin Technopole—will serve as a critical catalyst for the city's next wave of innovation. Strategically located in the heart of the Northern Metropolis, the Campus is poised to become a flagship landmark for AI+ and beyond, aiming to promote its widespread development and application across year, WAIC 2025, themed "Global Solidarity in the AI Era," will bring together top scientists, global leaders, entrepreneurs, policymakers, and innovators in the AI participation at WAIC 2025 is a testament to Hong Kong's role as a bridge between Chinese and global innovators, fostering collaboration and exchange of ideas, technologies, and governance #HKSTP The issuer is solely responsible for the content of this announcement. About Hong Kong Science and Technology Parks Corporation Hong Kong Science and Technology Parks Corporation (HKSTP) was established in 2001 to create a thriving I&T ecosystem grooming 13 unicorns, more than 15,000 research professionals and over 2,300 technology companies from 26 countries and regions focused on developing healthtech, AI and robotics, fintech and smart city technologies, etc. Our growing innovation ecosystem offers comprehensive support to attract and nurture talent, accelerate and commercialise innovation for technology ventures, with the I&T journey built around our key locations of Hong Kong Science Park in Pak Shek Kok, InnoCentre in Kowloon Tong and three modern InnoParks in Tai Po, Tseung Kwan O and Yuen Long realising a vision of new industrialisation for Hong Kong, where sectors including advanced manufacturing, micro-electronics and biotechnology are being reimagined. Hong Kong Science Park Shenzhen Branch in Futian, Shenzhen plays positive roles in connecting the world and the mainland with our proximity, strengthening cross-border exchange to bring advantages in attracting global talent and allowing possibilities for the development of technology companies in seven key areas: Medtech, big data and AI, robotics, new materials, microelectronics, fintech and sustainability, with both dry and wet laboratories, co-working space, conference and exhibition facilities, and more. Through our R&D infrastructure, startup support and enterprise services, commercialisation and investment expertise, partnership networks and talent traction, HKSTP continues to contribute in establishing I&T as a pillar of growth for Hong Kong. More information about HKSTP is available at
The Star
15 hours ago
- The Star
Japan discards state-acquired Covid-19 drugs worth US$1.6bil
TOKYO: (Bernama-Kyodo) The Japanese government discarded Covid-19 oral medicines believed to be worth around 240 billion yen (US$1.6 billion) in the fiscal year through March as they had passed their expiry dates, Kyodo News Agency reported, citing health ministry officials on Wednesday (July 16). While the exact purchase price remains unclear, the value was calculated in accordance with current prices. The amount is enough to treat some 2.5 million people. The government acquired the oral drugs at the height of the coronavirus pandemic and provided them free of charge to hospitals and clinics nationwide. But many of them were unused after Covid-19 was downgraded to the same category as seasonal influenza in May 2023, which required people to pay for Covid-19 treatment. Drugmakers had also started general distribution of Covid-19 medicine in Japan themselves. A Ministry of Health, Labour and Welfare official said offering the drugs to other countries was considered but legally difficult. Among the two million doses of Pfizer Inc.'s nirmatrelvir and 1.6 million doses of Merck & Co.'s molnupiravir procured by the government, about 1.75 million doses of nirmatrelvir and some 780,000 doses of molnupiravir were disposed of, according to the ministry. The government also secured two million doses of Shionogi & Co.'s ensitrelvir but about 1.77 million of them are unused, the ministry said. They are expected to be discarded after they reach their expiration dates starting next fiscal year. - Bernama-Kyodo
